Fulcrum TherapeuticsFULC

那斯達克 · USD
3.85
+0.01
(+0.26%)
收盤 09/05 03:59 (UTC+8)
09/05 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • 0.80
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
-
-
-
-
-
-
-
-
80,000
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
80,000
-
營業費用
29,31022,18622,69321,85819,815-19,42925,12627,50829,834
研發費用
12,44414,08415,41614,29612,98713,40411,71314,63917,26119,773
推銷及管理費用
7,4628,1027,2777,5626,8286,9997,7168,42410,24710,061
非經常性項目費用
9,404------2,063--
其他營業費用
----------
營業利益
-19,906
-22,186
-22,693
-21,858
-19,815
-20,403
-19,429
-25,126
52,492
-29,834
其他收入及費用
3,1313,2952,3592,2632,5192,7482,8613,4302,9172,964
利息費用
----------
稅前純益
-26,179
-18,891
-20,334
-19,595
-17,296
-17,655
-16,568
-21,696
55,409
-26,870
所得稅
----------
稅後純益
-26,179
-18,891
-20,334
-19,595
-17,296
-17,655
-16,568
-21,696
55,409
-26,870
基本每股稅後盈餘(元)
-0.34-0.25-0.31-0.31-0.28-0.28-0.31-0.350.89-0.43
稀釋每股稅後盈餘(元)
-0.34-0.25-0.31-0.31-0.28-0.28-0.27-0.340.88-0.43
基本平均股數(千股)
76264.0076215.0065781.0062597.0062544.0062479.0053954.0062409.0062205.0061984.00
稀釋平均股數(千股)
76264.0076215.0065781.0062597.0062544.0062479.0053954.0062409.0063587.0061984.00
還原基本每股稅後盈餘(元)
-0.34-0.25-0.31-0.31-0.28-0.28-0.31-0.350.89-0.43
還原稀釋每股稅後盈餘(元)
-0.34-0.25-0.31-0.31-0.28-0.28-0.27-0.340.88-0.43
還原基本平均股數(千股)
76,26476,21565,78162,59762,54462,47953,95462,40962,20561,984
還原稀釋平均股數(千股)
76,26476,21565,78162,59762,54462,47953,95462,40963,58761,984
EBITDA(千元)
-26,774-19,320-20,370-19,835-18,037-18,201-17,144-22,47954,651-27,552

大家都在看

HOT